A scientist at work at the Serum Institute of India, which is working on COVID-19 vaccines. Two Indian companies have received the green light to start human trials of their candidate vaccines. By Sanjay KumarJul. 6, 2020 , 4:55 PM Science’s COVID-19 reporting is supported by the Pulitzer Center. NEW DELHI—The apparent speed at which...
Reviewed by James Ives, M.Psych. (Editor) Milestone for therapeutic development of peptides against gastrointestinal disorders The fascinating family of trefoil factor peptides brings hope to both research and industry to improve the treatment of chronic disorders such as Crohn’s disease. For the first time, a team led by ERC awardee Markus Muttenthaler from the Faculty...
A medication used as a second line of defense against tuberculosis could enhance therapy for fear and anxiety disorders, according to a new clinical study. D-cycloserine (DCS) has landed itself on the World Health Organization’s list of essential medicines for its abilities to stop the growth of bacterial cell walls. In recent decades, however, mental...
Asthma does not seem to increase the risk of a person contracting COVID-19 or influence its severity, according to new research. Researchers say further study is needed but those with the chronic respiratory disease don’t appear to be at a higher risk of getting extremely ill or dying from coronavirus. “Older age and conditions such...
This news or article is intended for readers with certain scientific or professional knowledge in the field. Research produces dramatic results in laboratory studies involving fatal myelin disease that strikes children. A team led by Case Western Reserve University medical researchers has developed a potential treatment method for Pelizaeus-Merzbacher disease (PMD), a fatal neurological disorder...
Both cabotegravir and oral tenofovir/emtricitabine (TDF/FTC) have high efficacy for pre-exposure prophylaxis (PrEP) DURHAM, N.C. – Researchers from the HIV Prevention Trials Network (HPTN) announced today that the HPTN 083 clinical trial showed that a pre-exposure prophylaxis (PrEP) regimen containing long-acting cabotegravir (CAB LA) injected once every 8 weeks was superior to daily oral tenofovir/emtricitabine...
Natural killer immune cells engineered to target the PD-L1 molecule can directly kill tumour cells in mice and reduce the numbers of immunosuppressive cells harbouring PD-L1 in mice and humans Scientists have engineered natural killer immune cells that not only kill head and neck tumour cells in mice but also reduce the immune-suppressing myeloid cells...
NATIONAL INSTITUTES OF NATURAL SCIENCES SCHEMATIC MODEL OF FECAL RNA-MEDIATED SEROTONIN PRODUCTION. view more CREDIT: KENTA MARUYAMA In a new study published in Cell, “RNA sensing by gut Piezo1 is essential for systemic serotonin synthesis”, a research team led by Kenta Maruyama M.D., Ph.D. from National Institute for Physiological Sciences (NIPS) explored the role of...
Researchers in Korea have now developed a new method to power medical implants using an active photonic wireless system GIST(GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY) THE USE OF MEDICAL IMPLANTS IN HUMAN BODIES GENERATES THE NEED FOR INVASIVE SURGERY TO REPLACE EXHAUSTED BATTERIES, LEADING TO A HIGHER RISK OF SURGICAL COMPLICATIONS IN PATIENTS view more...
by Johannes Angerer, Medical University of Vienna CAR-T cell therapy is a new and revolutionary weapon against cancer: T cells are isolated from the patient’s blood for genetic modification and then infused back into the patient to attack cancer cells. Researchers from the Medical University of Vienna have now determined why CAR-T cells do not...
